Protection against malaria at 1 year and immune correlates following PfSPZ vaccination

Author:

Ishizuka Andrew SORCID,Lyke Kirsten E,DeZure Adam,Berry Andrea A,Richie Thomas L,Mendoza Floreliz H,Enama Mary E,Gordon Ingelise J,Chang Lee-Jah,Sarwar Uzma N,Zephir Kathryn L,Holman LaSonji A,James Eric R,Billingsley Peter F,Gunasekera Anusha,Chakravarty Sumana,Manoj Anita,Li MingLin,Ruben Adam J,Li Tao,Eappen Abraham G,Stafford Richard E,K C Natasha,Murshedkar Tooba,DeCederfelt Hope,Plummer Sarah H,Hendel Cynthia S,Novik Laura,Costner Pamela J M,Saunders Jamie G,Laurens Matthew B,Plowe Christopher V,Flynn Barbara,Whalen William R,Todd J P,Noor Jay,Rao Srinivas,Sierra-Davidson Kailan,Lynn Geoffrey M,Epstein Judith E,Kemp Margaret A,Fahle Gary A,Mikolajczak Sebastian A,Fishbaugher Matthew,Sack Brandon K,Kappe Stefan H I,Davidson Silas A,Garver Lindsey S,Björkström Niklas K,Nason Martha C,Graham Barney S,Roederer Mario,Sim B Kim Lee,Hoffman Stephen L,Ledgerwood Julie E,Seder Robert A

Publisher

Springer Science and Business Media LLC

Subject

General Biochemistry, Genetics and Molecular Biology,General Medicine

Reference49 articles.

1. World Health Organization. World malaria report 2015. (World Health Organization, 2015).

2. Hoffman, S.L. et al. The march toward malaria vaccines. Vaccine 33, D13–D23 (2015).

3. Kester, K.E. et al. Randomized, double-blind, phase 2a trial of falciparum malaria vaccines RTS,S/AS01B and RTS,S/AS02A in malaria-naive adults: safety, efficacy, and immunologic associates of protection. J. Infect. Dis. 200, 337–346 (2009).

4. RTS,S Clinical Trials Partnership. Efficacy and safety of RTS,S/AS01 malaria vaccine with or without a booster dose in infants and children in Africa: final results of a phase 3, individually randomized, controlled trial. Lancet 386, 31–45 (2015).

5. Plowe, C.V., Alonso, P. & Hoffman, S.L. The potential role of vaccines in the elimination of falciparum malaria and the eventual eradication of malaria. J. Infect. Dis. 200, 1646–1649 (2009).

Cited by 304 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3